| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 04/17/2001 | US6218392 For therapy and prophylaxis of ischemic heart diseases such as angina pectoris, myocardial infarct and chronic and acute cardiac failure, pulmonary hypertension, arteriosclerosis and bronchial asthma |
| 04/17/2001 | US6218391 Triazinones and derivatives thereof |
| 04/17/2001 | US6218385 1,2,4,5-Tetrahydro-benzo[D]azepin derivatives |
| 04/17/2001 | US6217856 Sunscreen agents |
| 04/17/2001 | CA2179396C Tetrahydrofuran antifungals |
| 04/17/2001 | CA2027765C Mevinic acid derivatives |
| 04/12/2001 | WO2001025233A1 Piperidine derivatives |
| 04/12/2001 | WO2001025232A1 Process for the preparation of paroxetine hydrochloride acetone solvate |
| 04/12/2001 | WO2001025231A1 Process for the preparation of paroxetine hydrochloride acetone solvate |
| 04/12/2001 | WO2001025230A1 Process for the preparation of paroxetine hydrochloride acetone solvate |
| 04/12/2001 | WO2001025220A1 Triazine kinase inhibitors |
| 04/12/2001 | WO2001025217A1 New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds |
| 04/12/2001 | WO2001025210A2 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof as adenosine receptor ligands |
| 04/12/2001 | WO2001025208A1 Pyridinium derivatives for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof |
| 04/12/2001 | WO2001025207A1 Novel nicotinonitrile compounds |
| 04/12/2001 | WO2001025200A1 Cyclic amine compounds as ccr5 antagonists |
| 04/12/2001 | WO2001025190A1 Novel diarylamide derivatives and use thereof as medicines |
| 04/12/2001 | WO2001024828A2 MODULATORS OF CYTOKINE MEDIATED SIGNALLING PATHWAYS AND INTEGRIN αVβ3 RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY |
| 04/12/2001 | WO2001024827A2 INHIBITORS OF THE ENDOTHELIN SIGNALLING PATHWAY AND αVβ3 INTEGRIN RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY |
| 04/12/2001 | WO2001024796A1 1,2,4-triazole derivatives, composition, process of making and methods of use |
| 04/12/2001 | WO1999063939A9 Multibinding inhibitors of cyclooxygenase-2 |
| 04/12/2001 | WO1999057117A3 Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation |
| 04/12/2001 | CA2608807A1 Cyclic amine compounds as ccr5 antagonists |
| 04/12/2001 | CA2386457A1 Inhibitors of the endothelin signalling pathway and .alpha.v.beta.3 integrin receptor antagonists for combination therapy |
| 04/12/2001 | CA2386218A1 Triazine kinase inhibitors |
| 04/12/2001 | CA2386147A1 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof |
| 04/12/2001 | CA2385972A1 Novel diarylamide derivatives and use thereof as medicines |
| 04/12/2001 | CA2385244A1 Novel nicotinonitrile compounds |
| 04/11/2001 | EP1090918A1 Amorphous paroxetine hydrochloride and method of producing it |
| 04/11/2001 | EP1089998A2 Epothilone derivatives and their synthesis and use |
| 04/11/2001 | EP1089997A1 4,5,6 and 7-indole and indoline derivatives, their preparation and use |
| 04/11/2001 | EP1089996A1 Paroxetine methanesulfonate |
| 04/11/2001 | EP1089995A1 Paroxetine ascorbate |
| 04/11/2001 | EP1089993A1 5-ht 1f? agonists |
| 04/11/2001 | EP1089989A1 Inhibitors of alpha4beta1 mediated cell adhesion |
| 04/11/2001 | EP1089980A1 Compounds for inhibiting beta-amyloid peptide release and/or its synthesis |
| 04/11/2001 | EP1089979A1 Substituted quinoxalin-2(1h)-ones useful as hiv reverse transcriptase inhibitors |
| 04/11/2001 | EP1089977A1 Compounds for inhibiting beta-amyloid peptide release and/or its synthesis |
| 04/11/2001 | EP1089964A1 Hydrazine derivatives |
| 04/11/2001 | EP1089735A1 4-benzyl piperidine alkylsulfoxide heterocycles and their use as subtype-selective nmda receptor antagonists |
| 04/11/2001 | EP0984963B1 Novel compounds |
| 04/11/2001 | CN1291192A 5,6,7-trino-4,8-inter-m-phenylene PGI2 derivative and drugs containing the same |
| 04/11/2001 | CN1291190A 5-substituted pyrimidine-2-yloxy carboxylic acid derivatives, the production of the same and their utilization as endothelin antagonist |
| 04/11/2001 | CN1291093A Pig appeasing pheromones to decrease stress, anxiety and aggressiveness |
| 04/11/2001 | CN1290698A Quinoline-4-base deviative I |
| 04/11/2001 | CN1064356C New piperazine, piperidine and 1,2,5,6-tetrahydropyridine compounds process for preparation thereof, and pharmaceutical composition containing them |
| 04/11/2001 | CN1064354C Trilcyclic benzazepine vasopressin antagnonists |
| 04/10/2001 | US6215016 Hematopoietic agents; preventing cytopenia |
| 04/10/2001 | US6214870 Antiarthritic agents; anticancer agents |
| 04/10/2001 | US6214858 Caspases and apoptosis |
| 04/10/2001 | US6214845 Insecticidal N-(substituted arylmethyl)-4[bis(substituted phenyl or pyridyl)methyl] piperidines |
| 04/10/2001 | US6214822 Substituted aza and diazacycloheptane and cyclooctane compounds and their use |
| 04/10/2001 | US6214813 Azopyrazoles |
| 04/10/2001 | US6214551 Oligonucleoside linkages containing adjacent nitrogen atoms |
| 04/10/2001 | CA2086974C R(+)-terazosin |
| 04/10/2001 | CA2077252C Methods of making ureas and guanidines, and intermediates therefor |
| 04/05/2001 | WO2001023381A1 Piperidine derivatives as reuptake inhibitors |
| 04/05/2001 | WO2001023380A1 Piperidine derivatives as serotonine reuptake inhibitors |
| 04/05/2001 | WO2001023378A1 Pharmaceutically active sulfonamide derivatives |
| 04/05/2001 | WO2001023376A1 Isonipecotamides for the treatment of integrin-mediated disorders |
| 04/05/2001 | WO2001023375A2 Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 04/05/2001 | WO2001023364A1 Quinazolinones |
| 04/05/2001 | WO2001023362A2 Rate-controlled particles |
| 04/05/2001 | WO2001023361A1 Pyrimidine derivatives, process for preparing the derivatives and drugs containing the same as the active ingredient |
| 04/05/2001 | WO2001023360A1 Aryl sulfonamide-substituted benzimidazol derivatives thereof as tryptase inhibitors |
| 04/05/2001 | WO2001023357A2 Fused cycloheptane and fused azacycloheptane compounds and their use as integrin receptor antagonists |
| 04/05/2001 | WO2001023353A2 Method for producing indole derivatives on a solid phase |
| 04/05/2001 | WO2001022966A1 Caspases and apoptosis |
| 04/05/2001 | WO2001022950A2 Diosolane nucleoside analogs for the treatment or prevention of viral infection |
| 04/05/2001 | WO2000073284A3 1,4-benzodiazepin-2-ones useful as hiv reverse transcriptase inhibitors |
| 04/05/2001 | WO2000068198A3 Heterosubstituted pyridine derivatives as pde 4 inhibitors |
| 04/05/2001 | WO2000066580A3 Antifungal ethers |
| 04/05/2001 | WO2000044362A3 The use of 4-h-1-benzopyran-4-one derivatives as inhibitors of smooth muscle cell proliferation |
| 04/05/2001 | DE19955087A1 Solid phase synthesis of indole derivatives comprises bonding of the indole nitrogen to a solid phase having vicinal diol groups by trans-acetalization of dialkoxymethyl protected indoles. |
| 04/05/2001 | DE19947440A1 1-Aziridino-1-hydroxyiminomethyl-Derivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel 1-Aziridino-1-hydroxyiminomethyl derivatives, processes for their preparation and medicaments containing these compounds |
| 04/05/2001 | CA2386092A1 Piperidine derivatives |
| 04/05/2001 | CA2386085A1 Piperidine derivatives |
| 04/05/2001 | CA2386074A1 Method for producing indole derivatives on a solid phase |
| 04/05/2001 | CA2385918A1 Quinazolinones |
| 04/05/2001 | CA2385349A1 Method for the treatment or prevention of viral infection using nucleoside analogues |
| 04/05/2001 | CA2385292A1 Pyrimidine compounds, processes for the preparation thereof and pharmaceutical compositions comprising the compounds as active ingredient |
| 04/05/2001 | CA2352957A1 Isonipecotamides for the treatment of integrin-mediated disorders |
| 04/04/2001 | EP1088821A1 Pharmaceutically active sulfonamide derivatives |
| 04/04/2001 | EP1088819A2 6-azauracil derivatives as thyroid receptor ligands |
| 04/04/2001 | EP1088818A1 Quinolin-4-yl derivatives |
| 04/04/2001 | EP1087964A1 N-benzodioxanylmethyl-1-piperidyl-methylamine compounds having affinity for 5-ht receptors |
| 04/04/2001 | EP1087963A1 Inhibitors of glycogen synthase kinase 3 |
| 04/04/2001 | EP1087961A1 Phenoxylpropanolamines, method for the production thereof and pharmaceutical compositions containing the same |
| 04/04/2001 | EP1087959A1 Novel benzopyran or thiobenzopyran derivatives |
| 04/04/2001 | EP1087948A1 2,4-diamino-1,3,5-triazine, method for the production and use of the same as herbicides and plant growth regulators |
| 04/04/2001 | EP1087946A1 Aryl alkanoylpyridazines |
| 04/04/2001 | EP1087938A1 Inhibitors of neuraminidases |
| 04/04/2001 | EP1087937A1 Cyclic hydroxamic acids as metalloproteinase inhibitors |
| 04/04/2001 | EP1087766A1 Method of treatment |
| 04/04/2001 | EP1087662A1 Composition for keeping away vermin |
| 04/04/2001 | EP0636127B1 Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity |
| 04/04/2001 | CN1290266A Benzofuran-4-carboxamides and their therapeutical use |
| 04/04/2001 | CN1290265A Thrombin receptor antagonists |
| 04/04/2001 | CN1290264A Triazine angiogenesis inhibitors |
| 04/04/2001 | CN1290263A Arylpiperidine derivatives and use thereof |